Sally Ward completed her Ph.D. research in the Department of Biochemistry, Cambridge University, Cambridge, U.K. in 1985. From 1985-1988 she was a Research Fellow at Gonville and Caius College whilst working at the Department of Biochemistry, Cambridge University. From 1988 to 1990, she held the Stanley Elmore Senior Research Fellowship at Sidney Sussex College and carried out research in Sir Greg Winter’s laboratory at the MRC Laboratory of Molecular Biology in Cambridge.
In 1990 she joined the University of Texas Southwestern Medical Center, Dallas, as an Assistant Professor. Since 2002, she was a Professor in the Department of Immunology at the same institution and in 2004 was appointed to the Paul and Betty Meek-FINA Professorship in Molecular Immunology. In 2014 she moved as Professor to Texas A&M University Health Science Center. She was recently appointed as Professor in Molecular Immunology and Director of Translational Immunology in the Centre for Cancer Immunology at the University of Southampton. Her research involves the use of interdisciplinary approaches using a combination of antibody/protein engineering, fluorescence imaging and in vivo studies to inform the design of antibody-based therapies for autoimmunity and cancer. She is a member of the Board of Distinguished Advisors in the Antibody Society and serves on the editorial boards of mAbs and Protein Engineering, Design and Selection. In 2010, she was founding co-organiser of the Gordon Research Conference ‘Antibody Biology and Engineering’.